Jody A. Charnow

Editor https://www.cancertherapyadvisor.com

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

AUA 2022

Neoadjuvant Axitinib May Enable Partial Nephrectomy in Complex Renal Tumors

Jody A. Charnow

May 23, 2022

An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.

AUA 2022

Study: Confirmatory Prostate Biopsies Still Needed Despite Upfront MRI

Jody A. Charnow

May 20, 2022

New findings challenge recommendations from the European Association of Urology.

AUA 2022

ICIs May Improve mRCC Outcomes in Cytoreductive Nephrectomy Cases

Jody A. Charnow

May 18, 2022

Immune checkpoint inhibitors may be more beneficial than tyrosine kinase inhibitors for patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma.

AUA 2022

UTUC in Octogenarians Frequently Managed Without Surgery

Jody A. Charnow

May 18, 2022

Approximately one-quarter of patients aged 80 years or older with upper tract urothelial carcinoma are managed expectantly, data show.

Prostate Cancer

New Model Improves Life Expectancy Estimates in Prostate Cancer Population

Jody A. Charnow

May 11, 2022

A novel life expectancy calculator could allow for more personalized management of men with prostate cancer.

IKCS Europe 2022

DNA Assay May Distinguish Responses to mRCC Immunotherapy

Jody A. Charnow

April 29, 2022

The TARDIS assay could be used to identify appropriate candidates for discontinuation of immune checkpoint inhibitors.

Renal Cell Carcinoma

Treatment Advances Have Upped Survival in Metastatic Kidney Cancer

Jody A. Charnow

April 28, 2022

Investigators in Austria studied overall survival in 914 patients diagnosed with mRCC from July 1985 to September 2020.

Renal Cell Carcinoma

Kidney Cancer Metastases Effectively Treated With Robotic Radiosurgery

Jody A. Charnow

April 27, 2022

Investigators examined outcomes of robotic radiosurgery in patients with lung, visceral, and lymph node metastases from renal cell carcinoma.

Renal Cell Carcinoma

Lenvatinib+Pembrolizumab Adverse Reactions in Advanced RCC Characterized

Jody A. Charnow

April 26, 2022

Investigators describe the type and frequency of adverse reactions and how clinicians managed them.

Bladder Cancer

Time to Metastasis May Be a Surrogate for UTUC Survival After Surgery

Jody A. Charnow

April 20, 2022

Distant metastasis emerged as the best candidate to be a surrogate endpoint for survival among patients receiving surgical treatment for upper tract urothelial carcinoma.

Next post in Bladder Cancer